In recent times, the panorama of pharmaceutical accessibility has undergone important modifications, significantly concerning medications like Provigil (modafinil), which is extensively used for its wakefulness-promoting properties. Initially developed to treat narcolepsy and different sleep disorders, modafinil has gained reputation off-label for its cognitive-enhancing results, leading to increased demand. This text
